Reimagining the Pharmaceutical Sales Rep Model in Asia – Brink – The Edge of Risk https://t.co/G4nPpGybiC — The Propell Group (@ThePropellGroup) August 22, 2017 #healthtech
Samsung jumps into risky but lucrative original drugs market https://t.co/zDLW9p6kTG via @FT — The Propell Group (@ThePropellGroup) August 22, 2017 #healthtech
Here’s what clinical trial utopia may look like – MedCity News https://t.co/2QezbOtAbb — The Propell Group (@ThePropellGroup) August 20, 2017 #healthtech
The Most Active Investors In Genomics https://t.co/Nx6pwGPfB9 — The Propell Group (@ThePropellGroup) August 20, 2017 #healthtech
India needs clarity and parity in the epharmacy business, says 1mg’s Prashant Tandon – VCCircle https://t.co/xU8LtuJlnY — The Propell Group (@ThePropellGroup) August 20, 2017 #healthtech
Apple Patent Aims To Turn Your iPhone Into A Health Data Tracker https://t.co/zh8HQiSXim — The Propell Group (@ThePropellGroup) August 17, 2017 #healthtech
Fast-tracking drug development one robot at a time https://t.co/oluqh1V6my — The Propell Group (@ThePropellGroup) August 16, 2017 #healthtech
Artificial Intelligence Is Stuck. Here’s How to Move It Forward. https://t.co/TCqzFWvc2H — The Propell Group (@ThePropellGroup) August 16, 2017 #healthtech
Is blockchain the driver for transformation in Healthcare we have been waiting for? | Pharma Magazine https://t.co/jIZNlo6t07 — The Propell Group (@ThePropellGroup) August 15, 2017 #healthtech
Interview: Annie Lamont and Andrew Adams of Oak HC/FT on AI, Regulation, Corporations, and more https://t.co/50te9ywj9p — The Propell Group (@ThePropellGroup) August 10, 2017 #healthtech